Management of early breast cancer in the elderly

International Journal of Cancer

Volumn 120, Issue 6, 2007, Pages 1155-1160

  Rao, Vittal S R ^a   Garimella, Veerabhadra ^a   Hwang, Meiju ^a   Drew, Philip J ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Chemotherapy; Conservative surgery; Elderly breast cancer; Primary endocrine treatment; Radiotherapy

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; DOXORUBICIN; ESTROGEN RECEPTOR; EXEMESTANE; FULVESTRANT; LETROZOLE; TAMOXIFEN;

AGED; AGING; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURVIVAL; CONSERVATIVE TREATMENT; DISEASE FREE SURVIVAL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EARLY CANCER; FEMALE; FRACTURE; GERIATRIC PATIENT; HIGH RISK POPULATION; HUMAN; LONG TERM CARE; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RISK; SENTINEL LYMPH NODE BIOPSY; SHORT SURVEY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS;

EID: 33846990900     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22431     Document Type: Short Survey

References (65)

1. Wanebo HJ, Cole B, Chung M, Vezeridis M, Schepps B, Fulton J, Bland K. Is surgical management compromised in elderly patients with breast cancer? Ann Surg 1997;225:579-89.
2. Holmes CE, Muss HB. Diagnosis and treatment of breast cancer in the elderly. CA Cancer J Clin 2003;53:227-44.
3. Zanon C, Chiappino I, Natta F, Capozzi MP, Alluminio P, Cirigliano W, Ballario F. Breast carcinoma in the elderly patient: which treatment? Minerva Chir 1993;48:915-19.
4. Wyld L, Reed MWR. The need for targeted research into breast cancer in the elderly. Br J Surg 2003;90:388-99.
5. Yoshinaga Y, Shirakusa T, Baba M, Beppu R, Hiratsuka M, Maekawa T, Kawahara K, Yamashita Y. Surgical treatment for elderly breast cancer patients over the age of 70. Int Surg 2003;88:169-74.
6. Fisher CJ, Egan MK, Smith P, Wicks K, Mills RR, Fentiman IS. Histopathology of breast cancer in relation to age. Br J Cancer 1997;75:593-96.
7. Hainsworth PJ, Henderson MA, Bennett RC. Breast cancer in the elderly, pattern of disease. Aust N Z J Surg 1991;61:892-7.
8. Elwood JM, Godolphin W. Oestrogen receptors in breast tumours: associations with age; menopausal status and epidemiological and clinical features in 735 patients. Br J Cancer 1980;42:635-44.
9. Veronesi U, Banfi A, Del Vecchio M, Saccozzi R, Clemente C, Greco M, Luiru A, Marubini E, Muscolino G, Rilke F. Comparison of Halsted mastectomy with quadrentectomy, axillary dissection and radiotherapy in early breast cancer: long term results. Eur J Cancer Clin Oncol. 1986;22:1085-9.
10. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, Fisher E, Deutsch M, Caplan R, Pilch Y. Eight year results of a randomised clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989;320:822-8.
11. Chetty U, Jack W, Prescott RJ, Tyler C, Rodger A. Management of the axilla in operable breast cancer treated by breast conservation: a randomized trial. Edinburgh Breast Unit. Br J Surg 2000;87:163-9.
12. Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN, Smith DC, George WD. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 1996;348:708-13.
13. Satariano WA. Comorbidity and functional status in older women with breast cancer: implications for screening, treatment and prognosis. J Gerontol 1992;47:24-31.
14. Newchaffer CJ, Bush TL, Penberthy LE, Bellatoni M, Helzslsour K, Diener-West M. Does comorbid disease interact with cancer? An epidemiologic analysis of mortality in a cohort of elderly breast cancer patients. J Gerontol A Biol Sci Med Sci 1998;53:M372-M378.
15. Balducci L, Yates J. General guidelines for the management of older patients with cancer. Oncology 2000;14:221-7.
16. Clark GM. The biology of breast cancer in older women. J Gerontol 1992;47:19-23.
17. Ciatto S, Cirillo A, Confortini M, Cardillo Cde L. Tamoxifen as primary treatment of breast cancer in elderly patients. Neoplasma 1996;43:43-5.
18. Cheung KL, Howell A, Robertson JF. Preoperative endocrine therapy for breast cancer. Endocr Relat Cancer 2000;7:131-41.
19. Mustacchi G, Milani S, Pluchinotta A, De Matteis A, Rubagotti A, Perrota A. Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: The G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly. Anticancer Res 1994;14:2197-200.
20. Margolese RG, Foster RS, Jr. Tamoxifen as an alternative to surgical resection for selective geriatric patients with primary breast cancer. Arch Surg 1989;124:548-50.
21. Robertson JF, Todd JH, Ellis IO, Elston CW, Blarney RW. Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer. BMJ 1988;297:511-14.
22. Mustacchi G, Ceccherini R, Milani S, Pluchinotta A, De Matteis A, Maiorino L, Farris A, Scanni A, Sasso F; Italian Cooperative Group GRETA. Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial. Ann Oncol 2003;14:414-20.
23. Fennessy M, Bates T, MacRae K, Riley D, Houghton J, Baum M. Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer. Br J Surg 2004;91:699-704.
24. Fentiman IS, Christiaens MR, Paridaens R, Van Geel A, Rutgers E, Berner J, de Keizer G, Wildiers J, Nagadowska M, Legrand C, Therasse P; EORTC. Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy. Eur J Cancer 2003;39:309-16.
25. Fentiman IS, van Zijl J, Karydas I, Chaudary MA, Margreiter R, Legrand C, Therasse P; EORTC, Treatment of operable breast cancer in the elderly, a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen. Eur J Cancer 2003;39:300-8.
26. Hind D, Wyld L, Beverley CB, Reed MW. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus). Cochrane Database Syst Rev 2006;1:CD004272.
27. Bonneterre J, Thurlimann B, Robertson JF, Krzakowski M, Mauriac L, Koralewski P, Vergote I, Webster A, Steinberg M, von Euler M. Anastrozole versus tamoxifen as first line therapy for advanced breast cancer in 668 post menopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study. J Clin Oncol 2000;18:3748-57.
28. Mouridsen H, Gershanovich M, Sun Y, Perez-Carrion R, Boni C, Monnier A, Apffelstaedt J, Smith R, Sleeboom HP, Janicke F, Pluzanska A, Dank M, et al. Superior efficacy of letrozole versus tamoxifen as first line therapy for post menopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. J Clin Oncol 2001;19:2596-606.
29. Paridaens R, Dirix L, Beex L, Nooij M, Cufer T, Lohrisch C, Biganzoli L, Van Hoorebeeck I, Duchateau L, Lobelle JP, Piccart M. Promising results with exemestane in the first line treatment of metastatic breast cancer: a randomised Phase II EORTC trial with a tamoxifen control. Clin Breast Cancer 2000;1:S19-S21.
30. Howell A, DeFriend D, Robertson J, Blamey R, Walton P. Response to a specific antioestrogen (ICI182780) in tamoxifen resistant breast cancer. Lancet 1995;345:29-30.
31. Howell A, Robertson JF, Quaresma AJ, Aschermannova A, Mauriac L, Kleeberg UR, Vergote I, Erikstein B, Webster A, Morris C. Fulvestrant, formerly ICI 182780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment. J Clin Oncol 2002;20:3396-3403.
32. Velanovich V, Gabel M, Walker EM, Doyle TJ, O'Bryan RM, Szymanski W, Ferrara JJ, Lewis FR, Jr. Causes for the undertreatment of elderly breast cancer patients: tailoring treatments to individual patients. J Am Coll Surg 2002;194:8-13.
33. August DA, Rea T, Sondak VK. Age related differences in breast cancer treatment. Ann Surg Oncol 1994;1:45-52.
34. Hunt KE, Fry DE, Bland KI. Breast carcinoma in the elderly patient: an assessment of operative risk, morbidity and mortality. Am J Surg 1980;140:339-42.
35. Reed MWR, Morrison JM. Wide local excision as the sole primary treatment in elderly patients with carcinoma of the breast. Br J Surg 1989;76:898-900.
36. de Haes JC, Curran D, Aaronson NK, Fentiman IS. Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial. Eur J Cancer 2003;39:945-51.
37. Salmon RJ, Remvikos Y, Campana F, Languille O, Magdalenat H, Asselain B, Clough KB. Neo adjuvant Tamoxifen in post menopausal patients with operable breast cancer. Eur J Surg Oncol 2003;29:831-4.
38. Cataliotti L, Buzdar AU, Noguchi S, Bines J, Takatsuka Y, Petrakova K, Dube P, de Oliveira CT. Comparison of anastrazole versus tamoxifen as pre-operative therapy in post-menopausal women with hormone receptor positive breast cancer: the pre-operative "Arimidex" compared to Tamoxifen (PROACT) trial. Cancer 2006;106:2095-103.
39. Truong PT, Wong E, Bernstein V, Berthelet E, Kader HA. Adjuvant radiation therapy after breast-conserving surgery in elderly women with early-stage breast cancer: controversy or consensus? Clin Breast Cancer 2004;4:407-14.
40. Gajdos C, Tartter PI, Bleiweiss IJ, Lopchinsky RA, Bernstein JL. The consequence of undertreating breast cancer in the elderly. J Am Coll Surg 2001;192:698-707.
41. Newlin ME. Reiling R, Nichols K. Necessity of axillary dissection in elderly women with early breast cancer. World J Surg 2002;26:1239-42.
42. Rudenstam CM, Zahrieh D, Forbes JF, Crivellari D, Holmberg SB, Rey P, Dent D, Campbell I, Bernhard J, Price KN, Castiglione-Gertsch M, Goldhirsch A, Gelber RD, Coates AS; International Breast Cancer Study Group. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol 2006;24:337-44.
43. Kelley MC, Gulliano AE. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. In: Bland KI, Copeland EM, eds. The Breast: Comprehensive Management of Benign and Malignant Disease, 2nd edn., vol. 2. Philadelphia, PA: WB Saunders, 1998. 1100-11.
44. Gennari R, Rotmensz N, Perego E, dos Santos G, Veronesi U. Sentinel node biopsy in elderly breast cancer patients. Surg Oncol 2004;13:193-6.
45. Clark GM, Osborne CK, McGuire WL. Correlations between oestrogen receptor, progesterone receptor and patient characteristics in human breast cancer. J Clin Oncol 1984;2:1102-09.
46. Early Breast Cancer Trialist's Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 1998;351:1451-67.
47. McDonald CC, Stewart HJ. Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee. BMJ 1991;303:435-7.
48. Crivellari D, Price K, Gelber RD, Castiglione-Gertsch M, Rudenstam CM, Lindtner J, Fey MF, Senn HJ, Coates AS, Collins J, Goldhirsch A; International Breast Cancer Study Group. Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV. J Clin Oncol 2003;21:4517-23.
49. Robertson JFR, Osborne CK, Howell A, Jones SE, Mauriac L, Ellis M, Kleeberg UR, Come SE, Vergote I, Gertler S, Buzdar A, Webster A, et al. Fulvestrant versus anastrazole for the treatment of advanced breast carcinoma in post menopausal women. A prospective combined analysis of two multicenter trials. Cancer 2003;98:229-39.
50. Coombes RC, Hall E, Gibson LJ, Paridaens R, Jassem J, Delozier T, Jones SE, Alvarez I, Bertelli G, Ortmann O, Coates AS, Bajetta E, et al.; Intergroup Exemestane Study A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350:1081-92.
51. Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Tu D, Shepherd LE, Pritchard KI, Livingston RB, Davidson NE, et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003;349:1793-802.
52. Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A, Sahmoud T; The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer 2003;98:1802-10.
53. Nemoto T, Patel JK, Rosner D, Dao TL, Schuh M, Penetrante R. Factors affecting recurrence in lumpectomy without irradiation for breast cancer. Cancer 1991;67:2079-82.
54. Gruenberger T, Gorlitzer M, Soliman T, Rudas M, Mittlboeck M, Gnant M, Reiner A, Teleky B, Seitz W, Jakesz R. It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients. Breast Cancer Res Treat 1998;50;37-46.
55. Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B, Wheeler J, Champion LA, Smith TJ, Smith BL, Shapiro C, Muss HB, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351:971-7.
56. Shah S, Doyle K, Lange EM, Shen P, Pennell T, Ferree C, Levine EA, Perrier ND. Breast cancer recurrences in elderly patients after lumpectomy. Am Surg 2002;68:735-9.
57. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, Blichert-Toft M, Mouridsen HT. Postoperative radiotherapy in big risk post menopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353:1641-48.
58. Kantorowitx DA, Poulter CA, Sischy B, Paterson E, Sobel SH, Rubin P, Dvoretsky PA, Mishalak W, Doane KL. Treatment of breast cancer among elderly women with segmental mastectomy or segmental mastectomy plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1988;15:263-70.
59. Valassiadou K, Robertson JFR. Efficacy of breast conserving surgery without adjuvant radiotherapy for invasive breast cancer in the elderly. Eur J Surg Oncol 2002;28:797.
60. Lee JC, Truong PT, Kader HA, Speers CH, Olivotto IA. Postmastectomy radiotherapy reduces locoregional recurrence in elderly women with high-risk breast cancer. Clin Oncol (R Coll Radiol) 2005;17:623-9.
61. Early Breast Cancer Trialist's Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomized trials. Lancet 1998;352:930-42.
62. Crivellari D, Bonetti M, Castiglione-Getsch M, Gelber RD, Rudenstam CM, Thurlimann B, Price KN, Coates AS, Hurny C, Bernhard J, Lindtner J, Collins J, et al. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J Clin Oncol 2000;18:1412-22.
63. Christman K, Muss HB, Case LD, Stanley V. Chemotherapy of metastatic breast cancer in the elderly. The Pidmont Oncology Association experience (comment). JAMA 1992;268:57-62.
64. Ibrahim NK, Buzdar AU, Asmar L, Theriault RL, Hortobagyi GN. Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: the M.D. Anderson experience with long-term follow-up. Ann Oncol 2000;11:1597-1601.
65. Fentiman IS. Improving the outcome for older women with breast cancer. Br J Surg 2004;91:655-6.